What Researchers Did
Researchers evaluated the effectiveness of hyperbaric oxygen therapy in 22 eyes of 20 patients with acute nonarteritic anterior ischemic optic neuropathy, comparing their outcomes to 27 untreated control patients.
What They Found
Both treated and control groups showed an increase in mean visual acuity at final examination, though the difference was not statistically significant. Similarly, mean visual field sensitivity loss minimally increased in both groups, with no significant difference between the 22 treated eyes and 27 control patients. No significant benefit was observed even when treatment was initiated within nine days of symptom onset.
What This Means for Canadian Patients
Canadian patients with acute nonarteritic anterior ischemic optic neuropathy should be aware that this study found no significant benefit from hyperbaric oxygen therapy. This suggests that this specific treatment approach may not be an effective option for improving visual outcomes.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A potential limitation of this study is the relatively small sample size of 20 treated patients and 27 controls, which might limit the generalizability of the findings.